Samsung Biologics signs manufacturing deal with European pharmaceutical company
Hand-out
Press Releases
Samsung Biologics  
November 19, 2024

Samsung Biologics signs manufacturing deal with European pharmaceutical company

The company will provide manufacturing services through 2031 in deals worth over USD 668 millionSamsung Biologics' cumulative contract value for 2024 surpasses USD 4 billion with latest deals

avatar profile Olean Times Herald

Olean Times Herald


Local & Social